Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Keeping track of certain health markers can help prevent serious health issues and even save lives. By monitoring these ...

Monday, Nov. 18 and 19, 2024 from 8 - 10 p.m. / PBS app. This is a two-part, four-hour documentary directed by Ken Burns, ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

Heart disease remains the number one cause of death in the U.S. And looking for warning signs, including shoulder pain, can ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

These disorders are frequently the outcome of atherosclerosis, a process in which plaque accumulates in the arteries, ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more ...

DOHA: The Ministry of Public Health (MoPH) has launched Qatar's National Action Plan on Obesity, Diabetes, and Modifiable ...

Clogged arteries, also known as atherosclerosis, happen when plaque builds up inside the arteries, which are blood vessels that carry oxygen-rich blood throughout the body. Plaque is made of ...